Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
HYC
HLTH
PRCD
ALMSM
Almirall SA€250
1EMEA
Dec 3, 2025
currency
EUR
size (m)
250.000
maturity
Jun 15, 2031
type
Fixed
tenor
5.500
call
2
registration
Reg S Only
benchmark
DBR
ranking
Sr. Unsecured
moody's
Ba2
s&p
BB+
fitch
-
size description
-
re-open/tap
No
ipt
Low 4s
ipt-pxd
-37.5
guidance
4% area; FINAL 3.75%-3.875%
spread
137
coupon
3.75%
spread set
-
price
100.00000
yield
3.75%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
-
active leads
joint leads
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
billing & delivering
-
active leads
joint leads
passive leads
-
co-managers
-
coordinating managers
-
Tranche Comments
First Pay: 2026-06-15; Redemption: 2027-12-15; Registration: Reg S Only; Comments: B&D: JPM. CoC: 101%;
Use of Proceeds
along with EUR55m cash on hand, to redeem its EUR300m 2.125% sr notes due 09/30/26 (callable at 100). Biz: a publicly listed pharmaceutical company that researches, develops, produces and markets a fairly diversified portfolio of in-house developed drugs and in-licensed drugs in therapeutic areas including dermatology, respiratory, gastrointestinal and pain relief. HQ: Barcelona, Spain.
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.